CoChat

Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis

Open access
Mission, John F., Ohno, Mika S., Cheng, Yvonne W., Caughey, Aaron B. · 2012 · American Journal of Obstetrics and Gynecology
Cited by 111

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Objective This study investigates the cost-effectiveness of gestational diabetes mellitus (GDM) screening using the new IADPSG guidelines. Study Design A decision analytic model was built comparing routine screening with the 2h OGTT vs. the 1-hour GCT. All probabilities, costs, and benefits were derived from the literature. Base-case, sensitivity analyses, and a Monte Carlo simulation were performed. Results Screening with the 2h GTT was more expensive, more effective, and cost-effective at $61,503/QALY. In a one-way sensitivity analysis, the more inclusive IADPSG diagnostic approach remained cost-effective as long an additional 2.0% or more of patients were diagnosed and treated for GDM. Conclusion Screening at 24-28 weeks GA under the new IADPSG guidelines with the 2h GTT is expensive but cost-effective in improving maternal and neonatal outcomes. How the health care system will provide expanded care to this group of women will need to be examined.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajog.2012.06.048

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 25

  1. Hillier, 2008, Screening for gestational diabetes mellitus: a systematic review for the US Preventive Services Task Force, Ann Intern Med, 148, 766, 10.7326/0003-4819-148-10-200805200-00009 · DOI · Paper page
  2. Landon, 2011, Gestational diabetes mellitus, Obstet Gynecol, 118, 1379, 10.1097/AOG.0b013e31823974e2 · DOI · Paper page
  3. Poncet, 2002, Cost-effectiveness analysis of gestational diabetes mellitus screening in France, Eur J Obstet Gynecol Reprod Biol, 103, 122, 10.1016/S0301-2115(02)00042-8 · DOI
  4. Landon, 2010, Is there a benefit to the treatment of mild gestational diabetes mellitus?, Am J Obstet Gynecol, 202, 649, 10.1016/j.ajog.2010.02.006 · DOI
  5. Caughey, 2005, Cost-effectiveness analysis of prenatal diagnosis: methodological issues and concerns, Gynecol Obstet Invest, 60, 11, 10.1159/000083480 · DOI
  6. Rouse, 1999, Prophylactic cesarean delivery for fetal macrosomia diagnosed by means of ultrasonography–a Faustian bargain?, Am J Obstet Gynecol, 181, 332, 10.1016/S0002-9378(99)70557-0 · DOI
  7. Clark, 2008, Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery, Am J Obstet Gynecol, 199, 36.e1, 10.1016/j.ajog.2008.03.007 · DOI · Paper page
  8. Kitzmiller, 2000, Cost analysis of diagnosis and treatment of gestational diabetes mellitus, Clin Obstet Gynecol, 43, 140, 10.1097/00003081-200003000-00014 · DOI
  9. Meltzer, 2010, Gestational diabetes mellitus screening and diagnosis: a prospective randomized controlled trial comparing costs of one-step and two-step methods, BJOG, 117, 407, 10.1111/j.1471-0528.2009.02475.x · DOI · Paper page
  10. Meads, 2008, Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modeling, Health Technol Assess, 12, iii, 10.3310/hta12060 · DOI · Paper page
  11. Bost, 2003, Cesarean delivery on demand: what will it cost?, Am J Obstet Gynecol, 188, 1418, 10.1067/mob.2003.455 · DOI
  12. Lloyd, 2009, Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK, Curr Med Res Opin, 25, 599, 10.1185/03007990802668208 · DOI
  13. Suresh, 2004, Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants, Pediatrics, 114, 917, 10.1542/peds.2004-0899 · DOI
  14. Phibbs, 2006, Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants, Early Hum Dev, 82, 85, 10.1016/j.earlhumdev.2006.01.001 · DOI · Paper page
  15. Culligan, 2005, Elective cesarean section to prevent anal incontinence and brachial plexus injuries associated with macrosomia–a decision analysis, Int Urogynecol J Pelvic Floor Dysfunct, 16, 19, 10.1007/s00192-004-1203-3 · DOI
  16. Grobman, 2000, Cost-effectiveness of elective cesarean delivery after one prior low transverse cesarean, Obstet Gynecol, 95, 745
  17. Angeja, 2006, Chilean women's preferences regarding mode of delivery: which do they prefer and why?, BJOG, 113, 1253, 10.1111/j.1471-0528.2006.01069.x · DOI · Paper page
  18. Kaimal, 2011, Cost-effectiveness of elective induction of labor at 41 weeks in nulliparous women, Am J Obstet Gynecol, 204, 137.e1, 10.1016/j.ajog.2010.08.012 · DOI
  19. Caughey, 2003, Quantitative evaluation of preference for mode of delivery in pregnant Chilean women, Med Decis Making, 23, 634
  20. Kuppermann, 2000, Procedure-related miscarriages and Down syndrome–affected births: implications for prenatal testing based on women's preferences, Obstet Gynecol, 96, 511
  21. Heron, 2009, Deaths: final data for 2006, Natl Vital Stat Rep, 57, 1
  22. Alwan, 2009, Treatments for gestational diabetes, Cochrane Database Syst Rev, 3
  23. Ratner, 2008, Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions, J Clin Endocrinol Metab, 93, 4774, 10.1210/jc.2008-0772 · DOI · Paper page
  24. Stasenko, 2010, Postpartum follow-up for women with gestational diabetes mellitus, Am J Perinatol, 27, 737, 10.1055/s-0030-1253557 · DOI
  25. Stasenko, 2011, Patient counseling increases postpartum follow-up in women with gestational diabetes mellitus, Am J Obstet Gynecol, 204, 522.e1, 10.1016/j.ajog.2011.01.057 · DOI

Cited by

Metadata

Authors
Mission, J. F., Ohno, M. S., Cheng, Y. W., & Caughey, A. B.
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
2012-10
Volume
207
Issue
4
Pages
326.e1-326.e9
ISSN
0002-9378 (ISSN-L)
OpenAlex
W2003722855
Cited by
111
References
12
FWCI
13.64
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • National Institutes of Health
  • University of California
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12 HD001262)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.